Partners

  • Abbvie

    At AbbVie, they have the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today, a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.

    Visit website
  • Janssen

    We're more than 30,000 people working hard to prevent, treat, cure and stop some of the most devastating and complex diseases of our time. From heart disease to HIV, Alzheimer's disease to cancer, we are committed to issues that touch everyone's lives.

    Visit website
  • Amgen

    With almost 40 years of experience in biotechnology, Amgen is a pioneer and expert in manufacturing biological medicines across different therapeutic areas, including inflammation. By developing several originator molecules and biosimilars in this field, Amgen will continuously deepen its commitment to patients and offer new treatment options to HCPs.

    Visit website
  • Biogen

    Biogen is a pioneer company in neuroscience. As one of the world’s first global biotechnology companies, Biogen has the leading portfolio to treat multiple sclerosis, introduced the first and only approved treatment for spinal muscular atrophy and continuously invests in advancing care in neuroscience. Biogen also manufactures and commercializes three anti-TNF biosimilars of advanced biologics in Europe. More than 100’000 patients have been treated with one of those biosimilars, contributing to expanding access to patients and the future of healthcare sustainability having generated estimated healthcare cost savings of 800 million Euro annually across Europe.

    Visit website
  • MSD

    We want to make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.

    Our mission is to discover, develop and provide innovative products and services that save and improve lives around the world.

    Visit website
  • Pfizer

    Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That's why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them.

    Pfizer has a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer's disease and cancer.

    Visit website
  • Takeda Belgium SCA

    Mission
    We strive towards better health for patients worldwide through leading innovation in medicine.

    Takeda-ism
    We, the members of the Takeda Group, pledge to act with integrity at all times, especially when facing difficulties or challenges. "Integrity" refers to our compliance with the highest ethical standards, our fairness and honesty in conducting every activity, and our perseverance in pursuing the ideal forms for our operations and management. Through the demonstration of these qualities, we show our commitment to building trust and confidence in all the people around us, and our determination to continue to expand the business. These empower our progress in our global endeavours to fulfil our mission to "strive towards better health for patients worldwide through leading innovation in medicine".

    Together with our highest ethical standards it has become a vital part of our management – for today and tomorrow.

    Visit website
  • Chiesi

  • Mundipharma

    At Mundipharma we are committed to developing a diverse portfolio of medicines that meet societal needs. We aim to conduct our business in an ethical, transparent and responsible way, doing what’s right for our employees and partners, while contributing to the communities within which we operate. We look at things from a different perspective and are experts at identifying and developing the potential of medical innovations and biosimilars to help improve patient’s lives in meaningful ways and at an affordable cost to providers.

    Visit website
  • Dr Falk

    Innovative drugs for bowel and liver diseases.
    Their pharmaceuticals are used successfully to treat inflammatory bowel disease and cholestatic liver disease.
    They focus on modern formulations and specially designed delivery systems to ensure targeted release of the active drug.

    Visit website
  • Ferring NV/SA

    Ferring is a research-driven, specialty biopharmaceutical company with operations in 55 countries.
    Ferring develops, manufactures and markets pharmaceutical and biopharmaceutical drugs that span the human life cycle and has in particular developed excellence in peptide and endocrine research.
    Ferring philosophy, “People come first at Ferring”, is the cornerstone of our business. This means our patients, their families and advisers, healthcare professionals, our employees and those on whose lives we can make a positive impact with our expertise and resources.
    Improving people’s health through medicine on the body’s own terms; that is our core business intention.
    At Ferring we understand that our primary responsibility is the delivery of therapies that bring long-lasting benefiets to patients and in some instances save lives. We also understand that we need to do this in a way that maximizes the positive impact we have on our communities and the environment in which we operate.

    Visit website
  • Lamepro

    Improving quality of healthcare is a continuous challenge in a fast changing environment. Lamepro is committed to face this challenge by offering innovative pharmaceuticals to healthcare professionals and their patients.

    Together with our partners we focus on improving care and quality of life for patients with gastrointestinal (GI) diseases. We collaborate with healthcare professionals and GI-experts to search for, and market innovative medicines for the treatment of diseases of the digestive system.

    Visit website
  • Mylan

    For more than 55 years, Mylan has increased patient access and reduced overall
    healthcare costs by providing high quality, affordable, generic small molecules,
    complex orals, topicals and sterile injectables. Our efforts are now expanding to offer
    biosimilars. Mylan is committed to increasing access to a broad portfolio of high-quality, affordable
    biosimilars worldwide.
    Biosimilars play an important role in Mylan’s commitment to setting new standards in
    healthcare by offering quality alternatives to costly therapeutic options and increasing
    access to treatment for the 7 billion people around the world.
    Mylan has a combined portfolio of 16 biosimilar and insulin analog products in development,
    which is one of the industry’s largest and most diverse portfolios.
    Mylan has one of the most diverse and comprehensive oncology, immunology
    and endocrinology portfolios and pipelines in the industry. Our significant investment and
    development of our biosimilars portfolio, combined with our over 45 oncology therapeutic,
    supportive care and diagnostic products, has well-positioned us in this space

  • Roche

    As the world’s largest biotech company we work intensely to understand how diseases differ down to the molecular level so we can develop new tests and medicines that prevent, diagnose and treat diseases, and bring them to the patients who need them.
    We develop breakthrough medicines, improving the standard of care across oncology, immunology, infectious diseases, ophthalmology and neuroscience. We are also the world leader in in vitro diagnostics. These combined strengths in diagnostics and pharmaceuticals empower us to deliver a personalised healthcare strategy with the aim to fit the right treatment to the right patient.

    Visit website
  • Vifor Pharma België nv

    Vifor Pharma Group, is a global pharmaceutical company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.

    Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. Vifor Pharma Group has production sites in Switzerland and Portugal as well as a dynamic network of affiliates and partners offering broad market coverage all over the world.

    Visit website

LIST OF PARTICIPANTS

Legend:       Coordinating PI     Participants

1. BE-SMART | 2. CEDAR-UC | 3. COMBINED THERAPY OF BIOLOGICALS AND NEW ORAL DRUGS. | 4. DETECT | 5. DNA BANKING | 6. GENGISCAN | 7. HELP-AID | 8. I-CARE | 9. IMMUNIZATION | 10. LOVE | 11. PACIFIC | 12. PEDIATRIC | 13. SPARE
1 2 3 4 5 6 7 8 9 10 11 12 13
- - x x x x
Leila Amininejad x x x
Saskia Appelmans
Filip Baert x x x x x x
Thomas Billiet
Patrick Bontems
Peter Bossuyt x x x x x x
Guillaume Burnet
Peter Burvenich
Philippe Caenepeel
Olivier Cajot
Christophe Claessens x
Jean-Charles Coche
Jean-Louis Coenegrachts
Arnaud Colard x
Filip Couturier
Anneline Cremer x x
Cléo Croonen
Francois D'Heygere x
Steven De Coninck
Elisabeth De Greef x
Marc De Maeyer
Marc De Reuck
Elodie De Ruyck
Nicolas de Suray
Martine De Vos x x x x
Benedicte De Vroey
Stefan Delen
Marie-Armelle Denis
Pieter Dewint x x
Olivier Dewit x x x
Sophie Dewit x x
Joris Dutre
Marc Etienne
Marc Ferrante x x x x x
René Fiasse
Fernand Fontaine x x
Denis Franchimont x x x x x x
Pieter Hindryckx x
Ilse Hoffman
Evelien Humblet x
Saskia Ilegems
Guy Lambrecht x x x
Pierre Lammens
Claire Liefferinckx x
Triana Lobaton
Edouard Louis x x x x x
Elisabeth Macken x
Marie-Christine Mairlot
Jean-Marc Maisin
Fazia Mana x
Walter Margos
Fady Mokaddem
Kim Moubax
Vinciane Muls
Carmen Musala
Michele Ngassa
Maja Noman
Hanne Ooms
An Outtier
Romy Ouziel
Harald Peeters
Annelies Posen
Philippe Potvin
Lieven Pouillon
Jean-Francois Rahier x x x x x x
Catherine Reenaers x x x
João Sabino
Michael Schapira
Nathalie Schoofs
Nele Schoofs
Alexandra Sermeus
Francoise Smets
Michaël Somers
Dirk Staessen
Marjan Steppe
Beatrijs Strubbe x
Jo Swinnen
Clara Thienpont
Haydeh Vafa
Gert Van Assche
Stephanie Van Biervliet
Frank Van De Mierop
Gaëtan Van Den Steen
Jurgen Van Dongen
Evi Van Dyck
Andre Van Gossum
Philippe Van Hootegem x x
Catherine Van Kemseke
Wouter Van Moerkercke x x x
Steven Van Outryve
Stijn Vanden Branden x x x x
Jo Vandervoort
Gigi Veereman x
Severine Vermeire x x x
Annelies Verreth
Bram Verstockt
Francis Weyn
Barbara Willandt